Is high-dose chemotherapy with peripheral stem cell rescue a suitable option for elderly patients affected by aggressive non-Hodgkin's lymphoma?

Ann Oncol. 2005 May;16(5):837-8. doi: 10.1093/annonc/mdi140. Epub 2005 Mar 23.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Humans
  • Lymphoma, Non-Hodgkin / pathology
  • Lymphoma, Non-Hodgkin / therapy*
  • Male
  • Neoplasm Staging
  • Risk Assessment
  • Stem Cell Transplantation / methods*
  • Treatment Outcome